HomeInsightsStock Comparison

Ipca Laboratories Ltd vs Sat Kartar Shopping Ltd Stock Comparison

Ipca Laboratories Ltd vs Sat Kartar Shopping Ltd Stock Comparison

Last Updated on: Aug 04, 2025

Key Highlights

  • The Latest Trading Price of Ipca Laboratories Ltd is ₹ 1445 as of 04 Aug 12:36.
  • The P/E Ratio of Ipca Laboratories Ltd changed from 28.9 on March 2020 to 51.6 on March 2025 . This represents a CAGR of 10.14% over 6 yearsThe P/E Ratio of Sat Kartar Shopping Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The Market Cap of Ipca Laboratories Ltd changed from ₹ 17538 crore on March 2020 to ₹ 38088 crore on March 2025 . This represents a CAGR of 13.80% over 6 yearsThe Market Cap of Sat Kartar Shopping Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The revenue of Ipca Laboratories Ltd for the Mar '25 is ₹ 2272 crore as compare to the Dec '24 revenue of ₹ 2265 crore. This represent the growth of 0.31% The revenue of Sat Kartar Shopping Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Ipca Laboratories Ltd for the Mar '25 is ₹ 249.63 crore as compare to the Dec '24 ebitda of ₹ 483.19 crore. This represent the decline of -48.34% The ebitda of Sat Kartar Shopping Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Ipca Laboratories Ltd changed from ₹ 166.21 crore to ₹ 65.78 crore over 8 quarters. This represents a CAGR of -37.09% The net profit of Sat Kartar Shopping Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Ipca Laboratories Ltd changed from 9.68 % on March 2020 to 15.59 % on March 2025 . This represents a CAGR of 8.27% over 6 yearsThe Dividend Payout of Sat Kartar Shopping Ltd changed from 3.08 % on March 2024 to 0 % on March 2025 . This represents a CAGR of -100.00% over 2 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Ipca Laboratories Ltd

  • Ipca Laboratories Limited (IPCA) was incorporated on 19 October, 1949 under the name of 'The Indian Pharmaceutical Combine Association Limited.' Ipca is a fully integrated, pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments.
  • The products of the Company are now sold in over 100 countries across the globe.
  • The Company has 18 manufacturing units in India manufacturing API's and formulations for the world market. Ipca's APIs and Formulations produced at world class manufacturing facilities are approved by leading drug regulatory authorities including the US-Food and Drug Administration (FDA), UK-Medicines and Healthcare products Regulatory Agency (MHRA), South Africa-Medicines Control Council (MCC), Brazil-Brazilian National Health Vigilance Agency (ANVISA) and Australia-Therapeutic Goods Administration (TGA) with operations in over 100 countries.

About Sat Kartar Shopping Ltd

  • Sat Kartar Shopping Limited was incorporated as a Private Limited Company with the name of 'Sat Kartar Shopping Private Limited' vide Certificate of Incorporation dated June 29, 2012, issued by Registrar of Companies, Delhi.
  • Further, Company converted into a Public Limited Company & name of the Company was changed to Sat Kartar Shopping Limited & Registrar of Companies, Delhi has issued a New Certificate of Incorporation consequent upon conversion dated July 12, 2021.
  • Manprit Singh Chadha is the Promoter of the Company. The Company offer Ayurvedic products, and we are committed with the mission of promoting a healthier lifestyle.
  • It provide good quality ayurvedic products related to personal wellness of men & women and products related to address various diseases such diabetes, addiction, Joint pain, low immunity and others.

Ipca Laboratories Ltd News Hub

News

Ipca Laboratories schedules board meeting

Ipca Laboratories will hold a meeting of the Board of Directors of the Company on 11 Augus...

Read more

25 Jul 2025 11:11

News

Volumes soar at Ipca Laboratories Ltd counter

Coforge Ltd, Persistent Systems Ltd, ZF Commercial Vehicle Control System India Ltd, Tata ...

Read more

24 Jul 2025 11:00

News

Ipca Laboratories Ltd soars 1.02%, rises for third straight session

Ipca Laboratories Ltd rose for a third straight session today. The stock is quoting at Rs ...

Read more

15 Jul 2025 13:05

News

Ipca Laboratories to hold AGM

Ipca Laboratories announced that the 75th Annual General Meeting(AGM) of the company will ...

Read more

11 Jul 2025 17:40

News

Ipca Laboratories Ltd spurts 0.19%, up for five straight sessions

Ipca Laboratories Ltd rose for a fifth straight session today. The stock is quoting at Rs ...

Read more

08 Jul 2025 13:00

News

Ipca Laboratories Ltd soars 1.25%, Gains for third straight session

Ipca Laboratories Ltd is up for a third straight session in a row. The stock is quoting at...

Read more

12 Jun 2025 13:05

Sat Kartar Shopping Ltd News Hub

News

Sat Kartar Shopping to conduct board meeting

Sat Kartar Shopping will hold a meeting of the Board of Directors of the Company on 4 Augu...

Read more

01 Aug 2025 10:04

News

Board of Sat Kartar Shopping recommends final dividend

Sat Kartar Shopping announced that the Board of Directors of the Company at its meeting he...

Read more

17 May 2025 17:20

News

Sat Kartar Shopping to declare Quarterly Results

Sat Kartar Shopping will hold a meeting of the Board of Directors of the Company on 17 May...

Read more

16 May 2025 14:52

News

NSE SME Sat Kartar Shopping makes a robust debut

The scrip was listed at 153.90, at a premium of 90% compared with the initial public offer...

Read more

17 Jan 2025 11:47

SWOT Analysis Of Ipca Laboratories Ltd

Strength

2

S

Weakness

4

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Ipca Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Ipca Laboratories Ltd and Sat Kartar Shopping Ltd

Which company has a larger market capitalization, Ipca Laboratories Ltd or Sat Kartar Shopping Ltd?

Market cap of Ipca Laboratories Ltd is 36,837 Cr while Market cap of Sat Kartar Shopping Ltd is 270 Cr

What are the key factors driving the stock performance of Ipca Laboratories Ltd and Sat Kartar Shopping Ltd?

The stock performance of Ipca Laboratories Ltd and Sat Kartar Shopping Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ipca Laboratories Ltd and Sat Kartar Shopping Ltd?

As of August 4, 2025, the Ipca Laboratories Ltd stock price is INR ₹1452.0. On the other hand, Sat Kartar Shopping Ltd stock price is INR ₹171.8.

How do dividend payouts of Ipca Laboratories Ltd and Sat Kartar Shopping Ltd compare?

To compare the dividend payouts of Ipca Laboratories Ltd and Sat Kartar Shopping Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions